As of 2025-09-04, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 585.09 USD. This relative valuation is based on P/E multiples. With the latest stock price at 563.80 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is 3.8%.
The range of the Relative Valuation is 495.54 - 644.67 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 13.9x | 13.4x |
| Forward P/E multiples | 13.7x - 15.2x | 14.3x |
| Fair Price | 495.54 - 644.67 | 585.09 |
| Upside | -12.1% - 14.3% | 3.8% |
| Date | P/E |
| 2025-09-03 | 13.40 |
| 2025-09-02 | 13.74 |
| 2025-08-29 | 13.80 |
| 2025-08-28 | 13.78 |
| 2025-08-27 | 13.95 |
| 2025-08-26 | 13.97 |
| 2025-08-25 | 13.61 |
| 2025-08-22 | 14.01 |
| 2025-08-21 | 14.22 |
| 2025-08-20 | 14.05 |
| 2025-08-19 | 13.59 |
| 2025-08-18 | 13.64 |
| 2025-08-15 | 13.80 |
| 2025-08-14 | 13.45 |
| 2025-08-13 | 13.35 |
| 2025-08-12 | 13.23 |
| 2025-08-11 | 12.98 |
| 2025-08-08 | 13.38 |
| 2025-08-07 | 13.31 |
| 2025-08-06 | 13.20 |
| 2025-08-05 | 13.55 |
| 2025-08-04 | 13.59 |
| 2025-08-01 | 13.29 |
| 2025-07-31 | 12.97 |
| 2025-07-30 | 13.18 |
| 2025-07-29 | 13.27 |
| 2025-07-28 | 13.28 |
| 2025-07-25 | 13.39 |
| 2025-07-24 | 13.42 |
| 2025-07-23 | 13.61 |
| 2025-07-22 | 13.33 |
| 2025-07-21 | 12.97 |
| 2025-07-18 | 12.90 |
| 2025-07-17 | 13.07 |
| 2025-07-16 | 13.03 |
| 2025-07-15 | 13.03 |
| 2025-07-14 | 13.56 |
| 2025-07-11 | 13.50 |
| 2025-07-10 | 13.31 |
| 2025-07-09 | 13.14 |
| 2025-07-08 | 13.02 |
| 2025-07-07 | 12.79 |
| 2025-07-03 | 13.01 |
| 2025-07-02 | 13.02 |
| 2025-07-01 | 12.72 |
| 2025-06-30 | 12.48 |
| 2025-06-27 | 12.39 |
| 2025-06-26 | 12.39 |
| 2025-06-25 | 12.37 |
| 2025-06-24 | 12.42 |